Mesenchymal stem cells (MSCs) can donate mitochondria and rescue anthracycline-induced cardiomyocyte (CM) damage, although the underlying mechanisms remain elusive. We determined that the superior efficiency of mitochondrial transfer by human induced-pluripotent-stem-cell-derived MSCs (iPSC-MSCs) compared with bone marrow-derived MSCs (BM-MSCs) is due to high expression of intrinsic Rho GTPase 1 (MIRO1). Further, due to a higher level of TNFaIP2 expression, iPSC-MSCs are more responsive to tumor necrosis factor alpha (TNF-a)-induced tunneling nanotube (TNT) formation for mitochondrial transfer to CMs, which is regulated via the TNF-a/ NF-kB/TNFaIP2 signaling pathway. Inhibition of TNFaIP2 or MIRO1 in iPSC-MSCs reduced the efficiency of mitochondrial transfer and decreased CMs protection. Compared with BM-MSCs, transplantation of iPSC-MSCs into a mouse model of anthracycline-induced cardiomyopathy resulted in more human mitochondrial retention and bioenergetic preservation in heart tissue. Efficacious transfer of mitochondria from iPSC-MSCs to CMs, due to higher MIRO1 expression and responsiveness to TNF-a-induced nanotube formation, effectively attenuates anthracycline-induced CM damage.
INTRODUCTION
Anthracycline antibiotics, including doxorubicin (Dox), remain the cornerstone of treatment for a variety of malignancies (Arcamone et al., 2000) . Nonetheless, they are well known to cause dose-dependent, progressive myocardial damage known as anthracycline-induced cardiomyopathy (AIC), which hinders their broad clinical application (Chen et al., 2011) . As more cancer patients survive, AIC has become more prevalent and is now the leading cause of morbidity and mortality among such patients. Although there remains some controversy about the conflicting beneficial (anticancer) and detrimental (cardiotoxic) effects of anthracycline therapy, compelling evidence indicates that different mechanisms are involved. Of note, anthracycline antitumor efficacy is associated with nuclear DNA intercalation topoisomerase II inhibition and drug-DNA adduct formation (Capranico et al., 1989) . Cardiotoxicity is largely ascribed to oxidative stress and mitochondrial damage (Lebrecht et al., 2005) . Recent studies suggest that inhibition of mitochondrial biogenesis is the main pathology underlying AIC (Suliman et al., 2007) and is separate from its antineoplastic activity of topoisomerase II inhibition (Holm et al., 1989) . Although angiotensinconverting enzyme inhibitors alone or with b-blockers may limit the progression of AIC (Georgakopoulos et al., 2010) , the only curative therapy for those with severe heart failure is heart transplantation (Lenneman et al., 2013) .
Anthracycline-induced inflammation and mitochondrial damage can lead to disruption of the homeostasis of endogenous myocardial regeneration by direct cardiomyocyte (CM) death and depletion of resident cardiac progenitor cells (De Angelis et al., 2010) . It has been shown that transplantation of adult mesenchymal stem cells (MSCs) protects CMs against AIC (Pinarli et al., 2013) , but the underlying mechanisms remain unclear. They may be related to large variations in MSCs derived from different sources (Xin et al., 2010) . Compared with adult MSCs, single-cell colony-derived MSC lines from human pluripotent stem cells (PSCs) show the same phenotype as bone marrow (BM)-MSCs and exhibit tissue repair (Lian et al., 2010) and anti-inflammatory (Sun et al., 2015) actions. In addition, they have the advantage of less batch-to-batch variation and can be expanded to >120 population doublings without obvious senescence (Lian et al., 2010) . Apart from the secretion of paracrine factors (Amsalem et al., 2007) , recent studies also report efficacious direct mitochondrial transfer from induced PSC-derived MSCs (iPSC-MSCs) to injured cells as another mechanism to protect against tissue injury (Islam et al., 2012; Li et al., 2014) . Based on these observations and the fact that iPSC-MSCs display a much higher efficiency for mitochondria transfer than adult BM-MSCs in response to inflammation, we hypothesized that this higher mitochondrial transfer potential may be associated with some intrinsic molecules involved in mediating mitochondrial movement to the native cells after transplantation. In this study, we have revealed that functional mitochondrial transfer from human iPSC-MSCs plays a critical role in cardio-protection against Dox-induced mitochondrial damage. Importantly, we demonstrated that the higher efficiency of mitochondrial transfer from human iPSC-MSCs is attributed to high-level intrinsic expression of MIRO1, a mitochondrial Rho GTPase 1 that can modulate intercellular mitochondrial movement along microtubules (Ahmad et al., 2014) . Moreover, iPSC-MSCs were more responsive than BMMSCs to pro-inflammatory cytokine tumor necrosis factor alpha (TNF-a)-induced formation of tunneling nanotubes (TNT) (Wang et al., 2011) , through which mitochondria were transported.
RESULTS

Efficiency of Mitochondrial Transfer from iPSC-MSCs to CMs in Response to Dox-Induced Injury
We first examined the mitochondrial transfer from MSCs to neonatal mice CMs (NMCs) under Dox challenge. Co-culture of Celltrace-labeled NMCs (violet) and MitoTrackerlabeled MSCs (green) revealed mitochondrial transfer from MSCs to NMCs (Figures S1Ai-S1Aiv). In agreement with previous studies (Ahmad et al., 2014; Vallabhaneni et al., 2012) , in the co-culture of NMCs and MSCs, we detected only MitoTracker of MSCs in NMCs but no Celltrace of NMCs in MSCs. Co-culture of human MSCs with NMCs indicated that human mitochondrial COX-4 was detected in NMCs that were positive for TROPONIN expression (Figures S1Bv -S1Bvii). We further examined the mitochondrial transfer efficiency after 4, 12, 24, and 48 hr of co-culture. Compared with BM-MSCs, more effective mitochondrial transfer from iPSC-MSCs to NMCs was detected by fluorescence-activated cell sorting (FACS) after 24 and 48 hr co-culture (Figures 1Ai and 1Aii) . Moreover, the mitochondrial transfer ratio of MSCs to NMCs at 48 hr was similar to that at 24 hr, indicating that 24 hr co-culture of MSCs with NMCs achieved the peak efficiency of mitochondrial transfer with and without Dox challenge. Notably, mitochondrial uptake was enhanced when NMCs were exposed to Dox, suggesting that injured NMCs increased the uptake of mitochondria from iPSCMSCs (Figure 1Aii ). We also examined the mitochondrial transfer efficiency from iPSC-MSCs to adult mice HL-1 or human AC16 CMs. Compared with NMCs, no significant difference in mitochondrial transfer ratio was observed from iPSC-MSCs to either HL-1 or AC16 CMs ( Figure S1C ), indicating that the efficiency of mitochondrial transfer from MSCs to CMs is not determined by the stage of CMs, but more likely the conditions to which they are exposed.
To exclude the possibility of leakage of MitoTracker green dye taken up by NMCs from medium, we transfected iPSCMSCs with a lentiviral-mediated mitochondrial-specific fragment fused with GFP (LV-MITO-GFP), allowing us to monitor mitochondrial trafficking. MITO-GFP-iPSC-MSCs ( Figure 1Bi ) were co-cultured with NMCs for 24 hr under Dox challenge. Immunostaining showed that TROPONIN-positive NMCs were positive for MITO-GFP, indicating that mitochondria had translocated from MSCs to NMCs (Figures 1Bii-1Biv ). We also co-cultured unlabeled NMCs with pLL3.7-GFP lentivirus-labeled iPSC-MSCs under Dox for 24 hr. Unlabeled NMCs were separated from the co-culture. Isolated NMCs were subjected to immunostaining for anti-TROPONIN and antihuman mitochondrial COX-4. We observed the presence of human COX-4 in NMCs, indicating that mitochondrial transfer had occurred between iPSC-MSCs and NMCs (Figures 1Ci-1Ciii ).
Functional Mitochondrial Transfer by iPSC-MSCs
Protects against Dox-Induced CM Damage and Is Independent of Paracrine Action of MSCs We examined whether mitochondria transferred from MSCs to NMCs are functional. Celltrace-labeled NMCs and MITO-GFP-iPSC-MSCs were co-cultured for 24 hr under Dox challenge. Cells were separated by cell sorting (Figure 1Di ). To verify the successful separation, immunostaining showed that TROPONIN-positive cells were co-localized with MITO-GFP in mitochondrial-transferred NMCs (Figure 1Dii ), and no MITO-GFP was detected in non-mitochondrial-transferred NMCs (Figure 1Diii ). To determine the respiratory function of transferred mitochondria, the cellular oxygen consumption rate (OCR) of NMCs with and without transferred mitochondria was examined. The bioenergetics profiles of different groups of NMCs are shown in Figure 1E . Four measurements were made: (1) basal mitochondrial OCR measured in medium containing 4.5 g/L glucose; (2) after inhibition of ATP synthase with oligomycin (Olig) (1 mM), ATP synthesis turnover and respiration driving proton leak were assessed by measuring OCR; (3) after treatment with the uncoupling agent carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) (2 mM), maximal mitochondrial respiratory capacity was determined by OCR; and (4) non-mitochondrial respiration was assessed by measuring OCR after treatment with complex I inhibitor, rotenone (Rot) (2 mM). Compared with control NMCs, basal mitochondrial OCR, ATP production, and maximum respiration were significantly decreased in the Dox-treated NMCs but greatly recovered in NMCs isolated after co-culture with iPSCMSCs ( Figure 1F ). Basal mitochondrial OCR, ATP production, and maximum mitochondrial respiratory function were markedly improved in NMCs with mitochondria (D) After co-culture, the mitochondrial-transferred and the non-mitochondrial-transferred NMCs were separated by FACS (Di). Representative images illustrating MITO-GFP expression in mitochondrial-transferred NMCs (Dii) but not in non-mitochondrial-transferred NMCs (Diii).
(E) OCR of NMCs from different groups was measured over time (minutes). The injection order of Olig, FCCP, and Rot are shown.
(F) Basal mitochondrial OCR (Fi), ATP production (Fii), and maximum respiration (Fiii) of NMCs from different groups was calculated (*p < 0.01 versus control; #p < 0.01 versus Dox; yp < 0.01 versus non-mitochondrial transfer). Data represent the means ± SD of three independent experiments.
transferred from MSCs compared with NMCs without transferred mitochondria ( Figure 1F ). We also tested the effect of mitochondrial transfer of MSCs on the viability of NMCs exposed to Dox challenge for 24 hr. Compared with control NMCs, Dox-induced necrosis of NMCs was dramatically attenuated after co-culture with MSCs ( Figures S2A and S2B) . Notably, using the same NMC and MSC co-culture system, after we separated mitochondrial-transferred NMCs from non-mitochondrial-transferred NMCs, cell death was far less for NMCs with transferred mitochondria, indicating that mitochondrial transfer from MSCs was protective against Dox, and such protection was independent of the paracrine action of iPSC-MSCs ( Figures S2A and S2B ). In addition, MSCs were less sensitive than CMs to Dox-induced cell death: 1 mM Dox treatment notably damaged NMCs (Figures S2A and S2B), whereas MSCs were not obviously affected ( Figure S2C ).
To further clarify that functional improvement was due to the transferred mitochondria, we compared the mitochondrial respiratory function of NMCs with transferred mitochondria, purified from either native iPSCMSCs or Rot-treated iPSC-MSC co-culture. Rot has been used to induce mitochondrial dysfunction (Ahmad et al., 2014) . Compared with control NMCs, mitochondrial OCR of NMCs was notably reduced after treatment with 50 nM Rot for 2 hr, although viability of NMCs was not affected (data not shown). Therefore, MITO-GFPiPSC-MSCs were treated with PBS or Rot for 2 hr and then co-cultured with Celltrace-labeled NMCs for 24 hr under Dox challenge. FACS analysis showed that the efficiency of mitochondrial transfer from Rot-treated and non-Rot-treated iPSC-MSCs to NMCs was similar (data not shown). Next, NMCs with transferred mitochondria were isolated from iPSC-MSCs or Rot-treated iPSC-MSCs, and OCR was measured. The bioenergetics profile of different groups is shown in Figure 2A . Compared with only Dox-treated NMCs, Dox-treated NMCs isolated from co-culture with iPSC-MSCs or Rottreated iPSC-MSCs presented markedly higher levels of basal mitochondrial OCR, ATP production, and maximum mitochondrial respiratory function (Figures  2Bi-2Biii) . Notably, compared with NMCs isolated from Rot-treated MSCs, NMCs isolated from iPSC-MSCs further showed a significantly higher level of basal mitochondrial OCR, ATP production, and maximum respiratory mitochondrial function, highlighting that only functional mitochondrial transfer could strongly protect NMCs. Those MSCs with impaired mitochondria (i.e., aged MSCs) may not be acceptable therapeutic donors. We also examined cytokines secreted by iPSC-MSCs and Rottreated iPSC-MSCs with or without TNF-a stimulation. There was no significant difference between MSCs and Rot-treated MSCs in the secretion of monocyte chemotactic protein-1 (MCP-1), interleukin-6 (IL-6), and interleukin-8 (IL-8), or vascular endothelial growth factor (VEGF), both in basal conditions and when stimulated by TNF-a (Figures 2Ci-2Civ) , suggesting that the functional protection afforded to NMCs by mitochondrial transfer is separate to the above paracrine effect.
iPSC-MSCs with High Potency of Mitochondrial Transfer Have High Expression of Intrinsic MIRO1
To explore the molecular basis of the higher efficiency of mitochondrial transfer by PSC-derived MSCs compared with BM-MSCs, we reviewed our previous microarray data (Lian et al., 2007 (Lian et al., , 2010 . Pairwise comparison of gene expression between human embryonic stem cell (hESC)/ iPSC-MSCs and BM-MSCs revealed a correlation coefficient of 0.72 (Lian et al., 2007) , suggesting significant conservation of gene expression in both hESC-MSCs and BM-MSCs, albeit with a few differences. A search for the distinguishing expression level of mitochondrial motor-protein-related genes among hESC-MSCs, iPSC-MSCs, and BM-MSCs, revealed that MIRO1, an integral protein involved in mitochondrial transportation (Ahmad et al., 2014) , is highly expressed by human iPSC-MSCs and hESC-MSCs but not BM-MSCs. Western blot confirmed that the protein level of MIRO1 is truly overpresented in human iPSCMSCs and hESC-MSCs compared with BM-MSCs ( Figures  3Ai and 3Aii) . To determine whether a high level of MIRO1 is a real key driver for the high level of intercellular mitochondrial transfer in iPSC-MSCs, we performed a loss-and gain-of function experiment by knockdown of MIRO1 with short hairpin RNA (shRNA) and replenishment by overexpression of MIRO1. Accordingly, MITO-GFP-iPSC-MSCs were introduced with scramble control shRNA (iPSC-MSCs-MIRO1 (Figures 3Ci-3Ciii ).
Formation of TNT between iPSC-MSCs and CMs for Mitochondrial Transfer
It has been reported that F-actin-modulated formation of TNT is a viable mechanism for mitochondrial transfer between adult stem cells and somatic cells and rescues their respiration (Spees et al., 2006; Vallabhaneni et al., 2012) . We examined in vitro the role of TNT in the regulation of iPSC-MSC mitochondrial transfer. MITO-GFP-iPSC-MSCs were co-cultured with Celltrace-labeled NMCs under Dox challenge. After 24 hr, staining with rhodamine phalloidin, a high-affinity F-actin probe, showed that NMCs and iPSCMSCs were bridged by TNT, which allowed effective transfer of iPSC-MSC mitochondria to injured NMCs , suggesting that TNT are vital for mitochondrial transfer. These findings were further confirmed by time-lapse filming, which enabled us to monitor mitochondrial movement via TNT between iPSC-MSCs and NMCs (Movies S1 and S2). We also examined TNT formation between MSCs and heathy NMCs: few TNT formations between MSCs and healthy NMCs were observed compared with MSCs and injured NMCs (data not shown). To determine whether NMCs could take up leaked MSC mitochondria from media without cell-cell connection, we treated cells with cytochalasin B (Figure 4B ), which causes F-actin aggregation and retards TNT formation by inhibiting actin polymerization and philiopodia elongation without affecting endocytosis (Abounit and Zurzolo, 2012; Cho et al., 2012) . Administration of cytochalasin B (350 nM) did not affect MSC viability (data not shown) but almost no TNT formation by iPSC-MSCs was observed ( Figure 4Biii ). Little mitochondrial transfer from MSCs was detected when NMCs were exposed to Dox (Figure 4Biv ), and the viability of NMCs was reduced, suggesting that cell-cell contact, such as TNT, is essential for intercellular mitochondrial transfer and to protect NMCs against Dox-induced damage. As expected, the FACS result showed that cytochalasin B treatment significantly reduced mitochondrial transfer from iPSC-MSCs to NMCs ( Figure 4C ).
To explore whether the mitochondrial transfer is uni-or bidirectional, we co-cultured MITO-GFP-NMCs with Sc , iPSC-MSCs-MIRO1 Lo , or iPSC-MSCs-MIRO1 Hi and stressed Celltrace-labeled NMCs (violet) were measured by FACS. We gated out violet+ NMCs and separated them into a violet+/GFP + population with mitochondria transfer (MITO-GFP + -NMCs) and a violet+/GFPÀ population without mitochondria transfer (MITO-GFP À -NMCs) to calculate the transfer ratio (violet+/GFP+ cells divided by the total violet+ cells). (C) (Ci) Western blot analysis for expression of GFP and human COX-4 in the mitochondrial-transferred NMCs that were isolated after coculture with iPSC-MSCs-MIRO1 Sc , iPSC-MSCs-MIRO1 Lo , or iPSC-MSCs-MIRO1 Hi . The expression of GFP (Cii) and human COX-4 (Ciii) among the different groups was evaluated. Data represent the means ± SD of three independent experiments. *p < 0.01.
Celltrace-labeled iPSC-MSCs for 24 hr under Dox challenge. Some MITO-GFP that originated from NMCs was detected in iPSC-MSCs although the level of MITO-GFP in iPSC-MSCs was much lower than in NMCs, suggesting that mitochondrial transfer is bidirectional, not unidirectional ( Figure S4 ).
Responsiveness of iPSC-MSCs to TNF-a-Induced Nanotube Formation Is Regulated via the TNF-a/ NF-kB/TNFaIP2 Signaling Pathway Stress conditions or TNF-a can stimulate the formation of TNTs between MSCs (Ahmad et al., 2014; Wang et al., 2011) . TNF-a was dramatically increased in mice with AIC ( Figure S7Diii ) and when NMCs were exposed to Dox challenge (from 360 ± 40 pg/mL to 5,880 ± 380 pg/mL, p < 0.01). TNT formation was increased when MSCs were exposed to TNF-a (20 ng/mL) ( Figure 5Ai ). PCR analysis showed that TNF-a-treated MSCs displayed a significantly increased expression of TNFaIP2, a TNF-a-induced protein that regulates TNT formation (Figure 5Aii ) (Ahmad et al., 2014; Hase et al., 2009 ). In addition, compared with BMMSCs, expression of TNFaIP2 was markedly higher in iPSC-MSCs responsive to TNF-a and was accompanied by a significant increase in TNT numbers per cell (Figure 5Aiii) . Nonetheless TNF-a-potentiated TNT formation was largely diminished by small interfering RNA (siRNA)-mediated knockdown of TNFaIP2 in both BM-MSCs and iPSCMSCs (Figures 5Ai-5Aiii ), indicating that TNFaIP2 is a downstream protein of TNF-a in the modulation of TNT formation. Depletion of TNF-a from iPSC-MSC medium by TNF-a antibody strikingly decreased the elevated expression of TNFaIP2 (Figure 5Bi) . Similarly, TNF-a-augmented TNT formation was largely decreased when TNF-a was depleted with TNF-a antibody in iPSC-MSC culture (Figure 5Bii) .
We co-cultured the TNFaIP2siRNA-treated iPSC-MSCs with NMCs and found TNT formation and mitochondrial transfer were abrogated in the TNFaIP2siRNA-treated group (Figures 5Ci and 5Cii) . Likewise, FACS analysis showed that after 24 hr co-culture of NMCs with control siRNA or TNFaIP2siRNA-treated iPSC-MSCs under Dox challenge, the mitochondrial transfer ratio in the iPSCMSCs-TNFaIP2 si group was significantly reduced compared with the iPSC-MSCs-con si group (Figure 5Ciii ). In contrast, compared with native BM-MSCs, TNT formation and the mitochondrial transfer ratio were significantly increased when BM-MSCs were overexpressed with TNFaIP2 under Dox challenge ( Figures S5A-S5C) . Further, the mitochondrial transfer ratio in the BM-MSCs-TNFaIP2 si group was significantly reduced compared with the BM-MSCs-con si group ( Figure S5D ). To determine whether TNFaIP2-induced TNT formation is mediated by the NF-kB pathway, we examined the phosphorylated level of NF-kB subunit P65 (P-P65) and TNT formation in iPSC-MSCs. TNF-a treatment enhanced TNT formation (Figures 5Di and 5Dii) , while the level of P-P65 and TNFaIP2 was also significantly increased (Figure 5Diii) . In contrast, treatment with NF-kB inhibitor SC-514 (1 mM) significantly attenuated the level of P-P65 and TNFaIP2, and abolished TNF-a-induced TNT formation (Figures 5Di and 5Dii) , suggesting that the TNF-a/ NF-kB/TNFaIP2 signaling pathway is predominantly involved in TNF-a-mediated TNT formation by MSCs. We also measured the expression of NF-kB and TNFaIP2 in the iPSC-MSCs-MIRO1 si and iPSC-MSCs-MIRO1 Hi .
The expression level of NF-kB activity and TNFaIP2 in both iPSC-MSCs-MIRO1 si and iPSC-MSCs-MIRO1 Hi was similar to the control iPSC-MSCs, indicating no direct relationship between MIRO1 and NF-kB/TNFaIP2 (data not shown).
Transplantation of iPSC-MSCs but Not TNFaIP2 si -
Treated iPSC-MSCs Effectively Protects against DoxInduced Cardiomyopathy
The experimental protocol is outlined in Figure 6A . Heart function was evaluated by echocardiogram and pressurevolume loop study (Figures 6B and 6C) . At week 0, administration of Dox significantly decreased the left ventricular (LV) ejection fraction (LVEF) and fractional shortening (FS) compared with the control group, indicating successful establishment of an animal model of Dox-induced cardiomyopathy (Figures 6Bi and 6Bii) . At 3 weeks after cell transplantation, LVEF, FS, LV +dp/dt, and LV systolic pressure (LVSP) were significantly improved in the MSC transplantation group compared with the Dox group ( Figure 6C ). The LVEF, FS, +dp/dt, and LVSP were also significantly higher in the iPSC-MSC group compared with the iPSC-MSCsTNFaIP2 si and BM-MSC groups ( Figure 6C ). Moreover, LV internal diameter end diastole (LVIDd) was greatly reduced and LV posterior wall end diastole (LVPWd) was significantly increased in the MSC transplantation group compared with the Dox group ( Figures S6A and S6B) . Notably, there were significant differences in LVIDd and LVPWd in the iPSCMSCs group compared with iPSC-MSCs-TNFaIP2 si and BM-MSCs groups ( Figures S6A and S6B ). Histological analysis revealed typical features of Dox-induced cardiotoxicity, including a dilated LV chamber, extensive CM death, myofibrillar degeneration, and vacuolization (Figures 6Di-6Dx ). MSC transplantation significantly attenuated LV dilatation and myocardial damage induced by Dox (Figures 6Di-6Dx ). Sirius red staining demonstrated a significantly increased extent of myocardial fibrosis in the Dox group compared with control group (Figures 6Dxi-6Dxv and 6E ). Nonetheless, 3 weeks after cell si on LVEF, FS, and LVSP were assessed at 3 weeks after cell injection (n = 6 mice per group). (D) At 3 weeks after cell transplantation, histological examination with H&E staining of heart tissue in different groups (Di-Dx). Compared with control mice, a dilated LV cavity and thinner LV walls were observed in Dox-treated mice. Histological sections of heart tissue displayed a different density of cardiomyocyte death, myofibrillar degeneration, and extensive vacuolization among experimental groups (Dvi-Dx). Sirius red staining showed a different degree of myocardium fibrosis among the different experimental groups (Dxi-Dxv). (E) Quantitative measurement of heart fibrosis in different experimental groups (n = 6 mice per group). Data represent the means ± SD. *p < 0.01 versus control; examined human mitochondria in heart tissue harvested 3 weeks after cell transplantation, abundant human mitochondrial protein COX-4 but not human nuclei antigen (HNA) was evident in the mouse TROPONIN-positive CMs, indicating that only human mitochondria from transplanted MSCs were retained in mouse CMs (Figures  7Ci-7Cxii ). Mice heart tissue with human COX-4-positive region was isolated by microdissection microscopy. PCR results for human DNA repeat sequences ALU-SX, mouse DNA repeat sequences C-mos (Lian et al., 2010) , human specific mtDNA, and mouse specific mtDNA (Sokolova et al.,
2004) indicated the presence of human mitochondrial genome but no human nuclear genome in the heart tissue ( Figure 7D ), in agreement with previous studies showing that direct mitochondrial transfer of MSCs plays a key role in tissue repair (Ahmad et al., 2014; Islam et al., 2012; Li et al., 2014) . Further, compared with BM-MSC-treated mice, iPSC-MSC-treated mice exhibited far more human COX-4-positive CMs ( Figure 7E ), suggesting more mitochondria of iPSC-MSCs remained in CMs. Nonetheless, the level of human mitochondrial COX-4 protein in mouse hearts was largely reduced in the iPSC-MSCs-TNFaIP2 si -treated mice compared with native iPSC-MSC-treated mice ( Figure 7E ), in line with in vitro evidence that inhibition of TNFaIP2 attenuated TNFa-stimulated mitochondrial transfer of iPSC-MSCs. In addition, Dox-induced reduction of ATP in heart tissue was notably reversed by MSC treatment ( Figure 7F ). The level of ATP was markedly increased 1.49-fold with iPSC-MSC treatment compared with BM-MSC treatment, whereas this elevation in iPSC-MSCs was markedly abrogated with iPSC-MSCs-TNFaIP2 si treatment, suggesting that TNFaIP2siRNA-pretreated iPSC-MSCs significantly lose their capacity to rescue Dox-induced mitochondrial damage ( Figure 7F ). Increased oxidative stress and excessive inflammation have been considered major mechanisms of Dox-induced cardiomyopathy (Takemura and Fujiwara, 2007) . We therefore evaluated the density of dihydroethidium (DHE), 3-nitrotyrosine (3-NT), and malonyldialdehyde (MDA), surrogate markers of oxidative stress. This showed that Dox-increased DHE ( Figures S7Ai-S7Avi ), 3-NT (Figures S7Bvii-S7Bxii), and MDA ( Figure S7Ai 
DISCUSSION
Several reports have shown that BM-MSCs can transfer mitochondria to other cells under various conditions (Cho et al., 2012; Jackson et al., 2016; Spees et al., 2006) . Recent results also demonstrate that mitochondrial transfer is an important mechanism of MSC therapy in tissue regeneration (Islam et al., 2012) and repair (Li et al., 2014) . The mechanisms of mitochondrial transfer from iPSC-MSCs remain elusive. It has been reported that MIRO1 plays a critical role in the regulation of intercellular mitochondrial transport from MSCs to airway epithelial cells, leading to increased application of MSC-based therapy (Ahmad et al., 2014) . Our study extends these observations: higher intrinsic MIRO1 in iPSC-MSCs compared with BM-MSCs contributed to higher mitochondrial transfer to NMCs than BM-MSCs. Indeed, inhibition of MIRO1 by shRNA reduced the efficiency of mitochondrial transfer by iPSC-MSCs, whereas overexpression of MIRO1 increased the efficiency. Emerging evidence suggests that paracrine factor profiling of MSCs is highly dependent on the microenvironment (Gao et al., 2016) . Paracrine factors of iPSCMSCs are reported to effectively rescue Dox-induced CM damage (Zhang et al., 2015) . Nevertheless, how the therapeutic efficacy of MSCs is increased in an inflammatory environment has not been well elucidated. Our results revealed crosstalk between the pro-inflammatory microenvironment and the provoked efficiency of mitochondrial transfer from MSCs. Importantly, functional mitochondrial transfer from iPSC-MSCs directly protects CMs against Dox-induced damage. The protection of mitochondrial transfer is separate to the paracrine actions of iPSC-MSCs because CMs without mitochondrial transfer in the same iPSC-MSC co-culture displayed poorer recovery of respiratory dysfunction. Alternatively, when co-culturing iPSCMSCs and CMs, non-mitochondrial-transferred CMs also exhibited strong resistance to Dox-induced damage, suggesting an important paracrine role of iPSC-MSCs (Zhang et al., 2015) . Paracrine action and mitochondrial transfer are two independent but interactive actions that afford MSC-mediated CMs protection against Dox insults. We determined that mitochondrial transfer of iPSC-MSCs can act as a ''Trojan horse'' through TNF-a induced formation of TNT in vitro. Although the mechanisms remain elusive, a higher level of TNFaIP2 detected in iPSC-MSCs may be responsible for enhanced TNT formation (Hase et al., 2009 ). We also discovered that a TNF-a/NF-kB/TNFaIP2 signaling pathway is predominantly involved in TNT development for MSC-mediated mitochondrial transfer, indicating that inflammation status may be a critical factor to increase the efficiency of mitochondrial transfer of MSCs, thus enhancing MSC-based therapeutic efficiency. TNF-a activates the NF-kB pathway, which subsequently stimulates TNFaIP2 expression (Chen et al., 2014) . Increased TNFaIP2 triggers F-actin polymerization, which may subsequently upregulate TNT formation through actin-driven protrusions of the cytoplasmic membrane in MSCs (Hase et al., 2009; Wang et al., 2011) . This contributes to mitochondrial donation from MSCs to NMCs. The mechanism of the high level of MIRO1 presented in iPSC/ECS-MSCs remains unknown. It has been proposed that compared with the pluripotent stage, during embryonic development, fetal growth, or lineage differentiation of PSCs, increased dynamic mitochondria biogenesis and mobility are needed to meet metabolic shifts for organ development (Teslaa and Teitell, 2015; Zhang et al., 2011) . Indeed, in our databases, we also found that not only MIRO1 but also other molecules involved in mitochondrial network fusion (MFN1 and MFN2) and optic atrophy 1 (OPA1), and mitochondrial mobility MIRO2 and Kif5b, were highly enriched in hESC/iPSC-derived MSC lines. What senses and instructs mitochondrial mass enrichment in lineage-specific MSCs and what other factors facilitate intercellular mitochondrial movement are subjects for future investigation. Whether other mitochondrial motor proteins contribute to intercellular mitochondrial transfer of iPSC-MSCs requires further study. Our results showed that a higher level of intrinsic MIRO1 as well as superior sensitivity to TNF-a-induced TNT formation contribute to the higher mitochondrial transfer potency in iPSC-MSCs. Our study reveals the protective effects of iPSC-MSCs against AIC by efficacious mitochondrial transfer from iPSC-MSCs to injured CMs, independently of MSC paracrine effects, and that augmentation of Dox-induced cardiomyopathy with iPSC-MSCs is attributed to an intrinsically high level of MIRO1 and high sensitivity to TNF-a-induced TNT formation. Our study raises the possibility that modulating mitochondrial transfer by MSCs might be an effective treatment of mitochondrial disorders including AIC.
This study has several limitations. First, our observations are based solely on in vitro and in vivo rodent models. The pathophysiological relevance of our findings should be confirmed in humanoid large animals and clinical studies. Second, although our data demonstrated the obligatory role of MIRO1 and TNT formation in mediating the efficiency of mitochondrial transfer from iPSC-MSCs via TNF-a/NF-kB signaling, the signaling pathways that link other mitochondrial motor proteins involved in intercellular mitochondrial donation need further investigation. Third, although we and others have observed no teratogenic effects of iPSC-MSCs in animal studies (Table S1 ) (Gruenloh et al., 2011; Lian et al., 2010) , the genomic stability of iPSCs needs to be evaluated carefully before their use is translated into clinical practice (Lister et al., 2011) . Fourth, the potential role of connexin-43-formed gap junctions (Islam et al., 2012) or microvesicle secretion (Phinney et al., 2015) in mitochondrial transfer has not been investigated in this study.
EXPERIMENTAL PROCEDURE
Cell Culture
Characterized BM-MSCs from healthy adults were commercially acquired from Cambrex BioScience (catalog no. PT-2501). Human iPSC-MSCs derived from iPSC lines were characterized as previously described (Lian et al., 2010 ). In the current study, two BMMSCs cell lines and two iPSC-MSCs (Lee NL-iPSC-MSCs and IMR90-iPSC-MSCs) were used. Primary NMCs were obtained and cultured. HL-1 cells, adult mice CM cell line, and adult human ventricular CM AC16 cells were cultured.
Animal Model
All experiments with live animals were carried out in accordance with relevant guidelines and regulations of the University of Hong Kong and approved by the Committee on the Use of Live Animals in Teaching and Research (CULTAR). A mouse model of AIC was induced in adult mice (6-8 weeks, ICR strain) by intraperitoneal injection of Dox (3 mg/kg, three times per week with a total cumulative dose of Dox of 18 mg/kg) (Zhang et al., 2015) . In the negative control group, healthy mice were injected with the same volume of PBS. Echocardiography was performed 1 week after the last Dox injection to confirm the successful creation of an AIC model. Mice with AIC were randomized to receive intramyocardial injection of (1) PBS (Dox group, n = 16), (2) Three weeks after cell transplantation, hemodynamic measurements were performed after the echocardiographic measurements.
Statistical Analysis
Values are expressed as means ± SD. Significant differences between groups were analyzed by unpaired Student's t test for two groups or one-way ANOVA followed by the Bonferroni test for multiple-group comparison. A p value <0.05 was considered statistically significant. Data represent the means ± SD of three independent experiments. *p<0.01.
SUPPLEMENTAL INFORMATION
AUTHOR CONTRIBUTIONS
Y
Overexpression of MIRO1 in NMCs has no impact on mitochondrial transfer from
MSCs to NMCs C) MIRO1 was measured in NMCs transfected with control plasmid 
Supplemental Experimental Procedures
Cell culture BM-MSCs and iPSC-MSCs were cultured with DMEM plus 10% fetal bovine serum (GIBCO), basic fibroblast growth factor (bFGF, 5ng/mL), and epidermal growth factor (EGF, 10ng/mL). Primary NMCs were obtained and cultured as previously reported (Chan et al., 2010 (Claycomb et al., 1998) , were maintained in modified Claycomb medium (Sigma-Aldrich)
supplemented with 10% fetal bovine serum (GIBCO), 100 μg/ml penicillin-streptomycin, 0.1 mM norepinephrine, and 2 mM L-glutamine. Adult human ventricular cardiomyocyte AC16 cells were cultured in DMEM F-12 supplemented with 12.5% fetal bovine serum (GIBCO) (Davidson et al., 2005) . Cells were diluted at a ratio of 1:4 when they reached confluence. Moreover, in-vitro co-culture experiments of NMCs, adult mice and human cardiomyocytes with MSCs were performed with and without Dox treatment. 5x10 5 NMCs were labeled with 1µM celltrace violet (Molecular Probes) for half an hour and washed with fresh medium. After washing and resting, MITO-GFP-MSCs and labeled NMCs were re-suspended in mixed medium and co-cultured at a 1:1 ratio in 24-well plates with cover slips in the presence of 1µM Dox. After 24 hours, the cells were washed with PBS and stained by phalloidin-rhodamine (5mg/mL, Sigma-Aldrich) and then visualized by laser confocal scanning microscopy (Zeiss LSM Meta 510).
Histological analysis
After echocardiographic and hemodynamic studies, mice were sacrificed. The hearts were harvested and fixed with 10% buffered formalin and then embedded in paraffin, and finally sectioned to 5-μm slides. Hematoxylin and eosin staining and Sirius red staining were performed. The degree of fibrosis was expressed as a percentage of the whole heart, and was measured by two independent investigators. The size of the fibrotic area was quantified with 6 randomly chosen high-power fields for each heart section, 6 mice for one group.
Animal model
Echocardiography was performed one week following the last Dox injection to confirm successful creation of an AIC model. Briefly, mice were anesthetized Three weeks after cell transplantation, and after echocardiographic measurement, hemodynamic measurements were performed. Briefly, a 1.4-Fr high-fidelity microtip catheter connected to a pressure transducer (Millar Instruments, Houston, TX, USA) was inserted into the LV cavity via the internal jugular artery to evaluate LV pressure and ±dp/dt using the Power Lab system (AD Instruments, Inc., Colorado Springs, CO, USA). All mice were then sacrificed, and histological examination to assess myocardial fibrosis, immunohistochemical staining, apoptosis and oxidative stress were performed.
Immunohistochemical staining
Immunohistochemical staining was performed according to the protocol. Briefly, following incubation with 5% bovine serum albumin for 30mins, heart sections were stained with primary antibodies and incubated overnight at 4°C with a 1:100 dilution.
The antibodies used in this study included anti-GFP (SC-8334, Santa Cruz), (1:1000), anti-rabbit IgG (1:1000) or anti-goat IgG (1:1000) was then used against the primary antibodies and incubated for 1 hr at room temperature. Finally, heart sections were washed and mounted with 4, 6-diamidino-2-phenylindole (DAPI) to stain the nucleus. Six mice from each group were analyzed; five sections were randomly collected from each mouse and then analyzed with a deconvoluted fluorescent microscope and Image J software.
TUNEL assay
According to the manufacturer's instructions, terminal deoxynucleotidal transferase mediated dUTP nick end-labeling (TUNEL) staining was carried out to detect apoptotic cells in the heart. Briefly, heart sections were washed and incubated with 1µg/mL Proteinase K/10mM Tris solution for 15mins at room temperature and washed twice in PBS and finally incubated with 100µL TUNEL reaction mixture in a humidified chamber for 1hr at room temperature. Sections were then washed 3 times with PBS, mounted with DAPI, observed under a fluorescent microscope and finally photographed. Six mice from each group were analyzed; five sections were randomly collected from each mouse and viewed for positive tunnel cell numbers.
DHE staining
The presence of superoxide anion (O2-) oxygen radicals generated by doxorubicin in the heart was evaluated by Dihydro-ethidium (DHE) staining. Briefly, the heart sections were incubated with DHE (2x10 -6 mol/L) at room temperature for 30mins. 
Determination of oxidative stress and inflammatory markers
Following the manufacturer's instructions, the concentration of MDA in the heart tissue from different experimental groups was measured by Thiobarbituric Acid
Reactive Substance Assay Kit (Cayman Chemical).
The concentrations of Monocyte chemotactic protein-1 (MCP-1) and TNF-α served as inflammatory markers in the different experimental groups and were measured using the mouse MCP-1 Elisa kit (KMC1011, Invitrogen) and mouse TNF-α Elisa kit (KMC3011, Invitrogen), respectively.
RT-PCR
RT-PCR was performed as previously described (Liang et al., 2015) . Total RNA was extracted using RNeasy kit (Qiagen, 74104). 1 µg of total RNA was used for the gene ration of first-strand cDNA using First-Strand cDNA Synthesis Kit (Takara, 6110) according to the protocol. Primers used in this study were as follows: human specific -AGCATCACGCTGGACTTGGG-3', R: 5'-CGGAAGGACAGGCAGTTGTT-3'. GAPDH was loaded as controls. PCR conditions were 36 cycles of 94°C for 1 minute, 55°C for 30 seconds, 72°C for 1 minute. The amplified products were determined by electrophoresis in 2.0% agarose gel containing ethidium bromide.
Western blot
Western blot was performed as previously described (Cheng et al., 2009) 
Assessments of mitochondrial transfer
Mitochondrial targeting transfection
Mitochondrial targeting green fluorescence protein (pCT-MITO-GFP, Cat:
Cyto102-PA-1, System Biosciences) was transfected according to the protocol. Briefly, 2x10 5 iPSC-MSCs or BM-MSCs were seeded one day before transfection. On the next day, lentiviral-mediated mitochondrial specific fragment fused with green florescence protein was added to 1 ml growth medium and incubated at 37 o C with a constant supply of 5% CO 2 for 16 hrs.
Flow cytometry analysis of mitochondrial transfer ratio
The mitochondrial transfer ratio from MSCs to NMCs was analyzed by fluorescence-activated cell sorting (FASC). Briefly, celltrace-labeled NMCs and mitotracker-labeled MSCs were co-cultured at a ratio of 1:1 in a 6-well plate with or without challenge of 1 µM Dox and examined after 4, 12, 24 and 48 hrs. Data were acquired by FACS flow cytometry with a 488nm argon laser and a 405nm laser and
